Company / Return on Assets (ROA)
Rein Therapeutics, Inc. Return on Assets (ROA) History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-260.3%
FY2025
5-year range
-260.3% / -25.3%
FY2021-FY2025
Trend
-928.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Return on Assets (ROA) changed -929% YoY in FY2025, a notable deviation from the 8-year average annual change of -159%.
Based on SEC 10-K filings.
-260.3% in FY2025 with a 5-year CAGR of -80.6%.
Declined from -25.8% to -260.3% over the past 2 years.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -136.1pp
- 5-Year Change
- -80.6pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, return on assets (roa) decreased 928.9% year-over-year.
- Peak return on assets (roa) was recorded in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -9.18 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -260.3% | -928.9% |
| FY2024 | -25.3% | +1.9% |
| FY2023 | -25.8% | +79.2% |
| FY2022 | -124.2% | -184.6% |
| FY2021 | -43.6% | +75.7% |
| FY2020 | -179.7% | -50.8% |
| FY2019 | -119.2% | -59.8% |
| FY2018 | -74.6% | -205.1% |
| FY2017 | -24.4% | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026